Unlock instant, AI-driven research and patent intelligence for your innovation.

Multi-modal tracing umbilical cord mesenchymal stem cell as well as preparation method and application thereof

A stem cell, multi-modal technology, applied in the field of biomedicine, can solve the problems of high requirements for detection objects, MRI comparison, and the difficulty of single-modal tracer to meet the application requirements, and achieve the effect of convenient efficacy evaluation.

Pending Publication Date: 2022-03-25
SUZHOU INST OF BIOMEDICAL ENG & TECH CHINESE ACADEMY OF SCI
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, the methods for tracing large animals in vivo are not perfect, and most of them are single-modal tracing, such as EGFP, iRFP, and Fluc; each single-modal imaging has its own advantages and disadvantages, such as MRI can obtain native three-dimensional cross-sections Imaging has a good ability to distinguish soft tissues, but it takes a long time to detect and has high requirements for the detection object; PET has higher sensitivity and specificity, and can perform quantitative analysis, but it cannot be compared with MRI in terms of clinical anatomy
Therefore, single-modal tracing has been difficult to meet the application requirements, and it is necessary to provide a solution that can realize multi-modal tracing

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Multi-modal tracing umbilical cord mesenchymal stem cell as well as preparation method and application thereof
  • Multi-modal tracing umbilical cord mesenchymal stem cell as well as preparation method and application thereof
  • Multi-modal tracing umbilical cord mesenchymal stem cell as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0101] Example 2 Construction of multimodal lentiviral expression vector

[0102] 1) Amplify the rFTH1-T2A gene fragment:

[0103] Using the plasmid containing the rFTH1-T2A gene as a template, use the following primer pair to amplify the rFTH1-T2A gene fragment by PCR, and introduce XbaI and AgeI restriction sites at both ends of the rFTH1-T2A gene fragment respectively;

[0104] PRTE-F:

[0105] 5'-CGGTGAATTCCTCGAGACTAGTTCTAGAGCCACCATGACCACCGCGTCT-3';

[0106] PRTE-R:

[0107] 5'-CTCCTCGCCCTTGCTCACCATGATACCGGTAGGGCCGGGATTCTCCTCCA-3';

[0108] 2) Use the pLVX-EGFP plasmid as a vector, digest it with XbaI and BamHI and use it for later use;

[0109] 3) Homologous recombination connection:

[0110] The rFTH1-T2A gene fragment obtained in step 1) is connected with the vector obtained in step 2) under the action of homologous recombinase to obtain the vector pLVX-rFTH1-T2A-EGFP;

[0111] 4) Synthesize the gene P2A-SR39RK fragment (synthesized by Jinweizhi Biotechnology Co.,...

Embodiment 3

[0114] Example 3 Lentiviral Packaging

[0115] 1) Spread 293T cells in a 10 cm culture dish one day before virus packaging, and carry out lentivirus packaging when the cell fusion degree is about 80%;

[0116] 2) Configure plasmid transfection systems A and B respectively:

[0117] System A includes 2mL OPTI and 50 μL PEI, system B includes 2mL OPTI and mixed plasmids, the mixed plasmids include 6.5 μg PMDL, 3.5 μg REV, 2.5 μg VSVG and 10 μg pLVX-rFTH1-P2A-SR39TK-T2A obtained in step 2) -EGFP;

[0118] 3-3) After the system A and system B are prepared, let them stand for 5 minutes respectively, then add system B dropwise to system A at a uniform speed, blow and suck several times, and incubate for 10 minutes to obtain the AB mixture;

[0119] 3-4) Discard the medium above the 293T cells, then slowly add the AB mixture along the side wall of the culture dish, and cultivate;

[0120] 3-5) Discard the AB mixture above the 293T cells after 8 hours, then slowly add complete medi...

Embodiment 4

[0126] Example 4 Establishment of multimodal tracer mesenchymal stem cell lines

[0127] 1) Recombinant lentivirus transfection: Plate the umbilical cord mesenchymal stem cells obtained in Example 1 18-24 hours before transfection, then add the recombinant lentivirus solution obtained in Example 3, incubate in a constant temperature incubator at 37°C, and transfect When the cell density is controlled at 70% to 90%;

[0128] 2) Pick a single clone: ​​After 48 hours, culture the umbilical cord mesenchymal stem cells infected with the recombinant lentivirus with 2ml of 0.25% Trypsin in a 10cm culture dish, and digest them in a 37°C incubator for 1-2min. The specific time depends on to the disappearance of cell synapses as a reference;

[0129] 3) Aspirate the Trypsin, add 2ml medium to stop the digestion and pipette the cells evenly into a cell suspension;

[0130] 4) Transfer the cell suspension to a 10ml centrifuge tube, centrifuge at 1000r / min for 5min, discard the supernata...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a multi-modal tracing umbilical cord mesenchymal stem cell and a preparation method and application thereof.The multi-modal tracing umbilical cord mesenchymal stem cell overexpresses FTH1 protein and SR39TK protein, and the preparation method comprises the steps that 1, umbilical cord mesenchymal stem cells are provided; 2) constructing a multi-modal lentivirus expression vector; 3) lentivirus packaging; and 4) transfecting the umbilical cord mesenchymal stem cells by using the recombinant lentivirus to construct the multi-modal tracing umbilical cord mesenchymal stem cell line. The umbilical cord mesenchymal stem cells can overexpress FTH1, SR39TK and EGFP, nuclear magnetic imaging, PET imaging and fluorescence imaging can be achieved at the same time in combination with the umbilical cord mesenchymal stem cells, tracing analysis of the dynamic distribution conditions of survival, distribution and migration after stem cell transplantation can be provided, and therefore great convenience is brought to evaluation of the curative effect of stem cell treatment; and a more powerful research basis and scientific basis are provided for experimental research and clinical application of the mesenchymal stem cells.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a multimodal tracer umbilical cord mesenchymal stem cell and its preparation method and application. Background technique [0002] In recent years, with the continuous improvement of people's living standards, the types of diets are rich and varied. Along with these changes, some new diseases have emerged, which has brought great challenges to medical and life science research. For some of the current diseases, traditional treatment methods may have been unable to do what they want. However, in recent years, the newly developed stem cell therapy with mesenchymal stem cells as the core has injected fresh blood into the current medical and biological research. Stem cell therapy, also known as regenerative medical technology, refers to the isolation and cultivation of stem cells in vitro, and certain gene modification or directional induction, and then transplantation to achieve the trea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/867C12N15/65A61K49/00A61K49/18A61K51/12
CPCC12N5/0668C12N15/86C12N15/65C12N9/1211C12Y207/01021C07K14/79A61K49/0002A61K49/0047A61K49/1896A61K51/1203C12N2740/15043C12N2510/00C12N2800/107
Inventor 张京钟曾东鳌余爽王娜娜汪婧雯武月牛晨旭周少聪
Owner SUZHOU INST OF BIOMEDICAL ENG & TECH CHINESE ACADEMY OF SCI